Related Experiment Video
Updated: Mar 25, 2026

Transmembrane Domain Oligomerization Propensity determined by ToxR Assay
Published on: May 26, 2011
Localization of the binding interface between leiomodin-2 and α-tropomyosin
Mert Colpan1, Dmitri Tolkatchev1, Samantha Grover1
1Voiland School of Chemical Engineering and Bioengineering, Washington State University, Pullman, WA 99164-6515, USA.
Abstract:
The development of some familial dilated cardiomyopathies (DCM) correlates with the presence of mutations in proteins that regulate the organization and function of thin filaments in cardiac muscle cells. Harmful effects of some mutations might be caused by disruption of yet uncharacterized protein-protein interactions. We used nuclear magnetic resonance spectroscopy to localize the region of striated muscle α-tropomyosin (Tpm1.1) that interacts with leiomodin-2 (Lmod2), a member of tropomodulin (Tmod) family of actin-binding proteins. We found that 21 N-terminal residues of Tpm1.1 are involved in interactions with residues 7-41 of Lmod2. The K15N mutation in Tpm1.1, known to be associated with familial DCM, is located within the newly identified Lmod2 binding site of Tpm1.1. We studied the effect of this mutation on binding Lmod2 and Tmod1. The mutation reduced binding affinity for both Lmod2 and Tmod1, which are responsible for correct lengths of thin filaments. The effect of the K15N mutation on Tpm1.1 binding to Lmod2 and Tmod1 provides a molecular rationale for the development of familial DCM.
Insights
Familial dilated cardiomyopathy (DCM) links to mutations affecting cardiac muscle thin filaments. A K15N mutation in α-tropomyosin disrupts interactions with leiomodin-2, explaining DCM development.
Area of Science:
- Cardiovascular Biology
- Molecular Muscle Physiology
- Protein Interaction Studies
Background:
- Familial dilated cardiomyopathy (DCM) is linked to mutations in cardiac muscle thin filament proteins.
- Uncharacterized protein-protein interactions may underlie the harmful effects of these mutations.
Purpose of the Study:
- To identify the interaction region between striated muscle α-tropomyosin (Tpm1.1) and leiomodin-2 (Lmod2).
- To investigate the impact of the familial DCM-associated K15N mutation in Tpm1.1 on Lmod2 and Tmod1 binding.
Main Methods:
- Nuclear magnetic resonance (NMR) spectroscopy was used to map the Tpm1.1-Lmod2 interaction site.
- Binding affinities of wild-type and K15N mutant Tpm1.1 to Lmod2 and Tmod1 were assessed.
Main Results:
- The N-terminal 21 residues of Tpm1.1 interact with residues 7-41 of Lmod2.
- The K15N mutation in Tpm1.1, located in the Lmod2 binding site, significantly reduced binding affinity for both Lmod2 and Tmod1.
- Lmod2 and Tmod1 are crucial for regulating thin filament length in cardiac muscle.
Conclusions:
- The K15N mutation impairs Tpm1.1 interactions with Lmod2 and Tmod1.
- This disruption provides a molecular explanation for the pathogenesis of familial DCM.
More Related Videos
Related Concept Videos
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Overview of Myosin Structure and Function
Ligand Binding and Linkage
Protein-protein Interfaces
Protein-Protein Interfaces
The Sarcomere
Each...

